Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
Obstetrics and Gynecology|December 21, 2011
Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivityIris L Romero, Anna McCormick, Kelsey A McEwen, et al.
Annals of Internal Medicine|July 9, 2004
Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled TrialChun-Su Yuan, Gang Wei, Lucy Dey, et al.
The Journal of Urology|September 23, 2003
Prognostic factors for survival with gemcitabine plus 5-fluorouracil based regimens for metastatic renal cancerWalter M Stadler, Dezheng Huo, Christopher George, et al.
European Journal of Haematology|February 2, 2023
A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myelomaBenjamin A Derman, Ajai Chari, Jeffrey Zonder, et al.
Journal of Clinical Pharmacology|April 16, 2005
Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humansChun-Su Yuan, Harold Doshan, Martha R Charney, et al.
Cancer Chemotherapy and Pharmacology|August 24, 2011
The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patientsJacqueline Ramírez, Kehua Wu, Linda Janisch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancerWalter M Stadler, Dingcai Cao, Nicholas J Vogelzang, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|December 26, 2007
Reproducibility and sources of variability in radiographic texture analysis of densitometric calcaneal imagesTamara J Vokes, Ann Pham, Joel Wilkie, et al.
Cancer Biology & Therapy|April 26, 2007
A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinomaEdwin M Posadas, Samir Undevia, Elizabeth Manchen, et al.
Pageof 15